We are live on ! Find out more
CMPX icon

Compass Therapeutics
CMPX

37 hedge funds and large institutions have $202M invested in Compass Therapeutics in 2021 Q4 according to their latest regulatory filings, with 37 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

64.85% more ownership

Funds ownership: 0% → 64.85% (+65%)

Holders
37
Holders Change
+37
Holders Change %
–
% of All Funds
0.57%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.08%
New
37
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
O
OrbiMed
New York
+$71.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$22.8M
3
RSCM
Rock Springs Capital Management
Maryland
+$17.7M
4
FCMV
Foresite Capital Management V
California
+$14.6M
5
CCM
Consonance Capital Management
New York
+$11.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$68.6M +$71.8M +21,642,975 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$21.8M +$22.8M +6,872,414 New
RSCM
3
Rock Springs Capital Management
Maryland
$16.9M +$17.7M +5,328,088 New
FCMV
4
Foresite Capital Management V
California
$13.9M +$14.6M +4,400,000 New
CCM
5
Consonance Capital Management
New York
$11.2M +$11.6M +3,500,000 New
CA
6
CHI Advisors
New York
$9.59M +$10M +3,023,692 New
APM
7
Avidity Partners Management
Texas
$6.34M +$6.63M +2,000,000 New
MIM
8
Monashee Investment Management
Massachusetts
$6.34M +$6.63M +2,000,000 New
VC
9
Vivo Capital
California
$6.34M +$6.63M +2,000,000 New
RCM
10
RA Capital Management
Massachusetts
$5.86M +$6.13M +1,849,518 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$4.99M +$5.22M +1,572,882 New
Blackstone Inc
12
Blackstone Inc
New York
$4.77M +$4.99M +1,505,738 New
Janus Henderson Group
13
Janus Henderson Group
United Kingdom
$4.7M +$4.88M +1,472,611 New
Adage Capital Partners
14
Adage Capital Partners
Massachusetts
$4.44M +$4.64M +1,400,000 New
FCOMV
15
Foresite Capital Opportunity Management V
California
$3.49M +$3.65M +1,100,000 New
FCM
16
Farallon Capital Management
California
$3.17M +$3.32M +1,000,000 New
FAM
17
Fred Alger Management
New York
$2.6M +$2.71M +818,745 New
SFM
18
Sphera Funds Management
Israel
$2.22M +$2.32M +700,000 New
DCM
19
Driehaus Capital Management
Illinois
$793K +$829K +250,000 New
OCA
20
Octagon Capital Advisors
New York
$761K +$796K +240,000 New
DCM
21
DAFNA Capital Management
California
$622K +$650K +196,091 New
AI
22
Alphabet Inc
California
$611K +$639K +192,794 New
LP
23
LMR Partners
United Kingdom
$317K +$332K +100,000 New
SIC
24
Salem Investment Counselors
North Carolina
$317K +$332K +100,000 New
IC
25
Ikarian Capital
Texas
$222K +$232K +70,000 New
1
2

CMPX Hedge Fund Activity: Q4 2021 in Review

37 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Compass Therapeutics (CMPX) for Q4 2021, worth a combined $202M.

Buyers outnumbered sellers: 37 funds opened new CMPX positions and 0 closed out — a net gain of 37 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $71.8M.

  • 37 institutional investors held Compass Therapeutics (CMPX) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $202M of Compass Therapeutics stock for Q4 2021.
  • 37 funds opened new Compass Therapeutics positions in Q4 2021 and 0 closed out, a net change of +37 holders.
  • The largest Compass Therapeutics buyer in Q4 2021 was OrbiMed, an estimated $71.8M added.

Based on aggregated 13F filings for Q4 2021.